smaller-logo1
From the Circle
A Newsletter from Chronic Illness Recovery

In This Issue
What's New?
Is IT for Everyone?
Inflammation Therapy
Therapy Tip
Scientific Article
CIR Policy
Quick Links

About Our Services

Who May Use Our Services

CIR's Unique Service

Forward to a Friend

Save the Date!

Sunday, Feb, 20, 2011
Our first-ever
Patient Seminar
in
Fort Worth - Dallas,
Texas

If you can arrange to be there, we would love to see you!

What's New?
keboarding
Question: Does CIR keep up with the latest developments related to inflammation therapy?

Answer: Yes, the Staff of Chronic Illness Recovery closely monitor research and developments pertaining to the science and management of inflammation therapy. Our online informational materials are updated daily by medical professionals to ensure they are accurate and current.
See
What's New?
 
Does Inflammation Therapy Work for Everyone?
keboarding
Find answers in
Efficacy and Expectations of Inflammation Therapy
 
CIR Organization

CIR is an IRS-recognized 501(c)3 non-profit,
charitable organization.

All donations are appreciated.

Donate Online Here

Quick Survey
We want to know how you use our website.

Please click here to take a survey.




Contact Information

CIR email address

Phone CIR toll-free
in the US and Canada 1-888-846-2474


Are you a Skype User?
Look for
Chronic.Illness.Recovery

Look for Chronic Illness Recovery on Facebook.


Issue: 7    April 2010
Greetings! 

girl_wateringLooking at the trees and flowers in their glorious bud and bloom, one can't help being reminded that all growing things respond to the proper attention. The same has been true of Chronic Illness Recovery, and I am thankful to all volunteers, supporters, and everyone else who has participated in this non-profit endeavor. 

Our website forums are thriving with vibrant, interesting discussions in the General Discussion area. Distribution of our monthly newsletter continues to grow as people find out about us and ask to be included.

CIR is reaching out to more doctors, so encourage medical professionals you know to request CIR's professional newsletter. Physicians, nurse practitioners and nurses need only to send an email request for the professional newsletter to: info@chronicillnessrecovery.org.

Belinda Fenter, CIR Director
About Inflammation Therapy
Frequently Asked Questions

What is the basic definition of Th1 inflammation?
See Immune System

Is inflammation therapy (IT) an applicable treatment for my disease or symptoms?
See Diseases Caused by Th1 Inflammation

What tests do I need to determine if inflammation therapy is the right treatment for me?
See D-Metabolite Tests

How can I find a supportive doctor?
See Doctor Search Suggestions

Why do I feel better in the summer and worse in the winter?
See Light Sensitivity

How will inflammation therapy affect my life? Can I continue to work?
See Work and Play on Inflammation Therapy

Why does inflammation therapy take so long?
See Recovery and the Healing Process

Benicar isn't available in my country / I can't afford Benicar. Is there an acceptable substitute?
See Benicar

Should I wear NoIRs, avoid natural light exposure and eliminate vitamin D before starting Benicar?
See Light Sensitivity

Should I stop taking any of my medications?
See Medications
This Month's Therapy Tip
Controlling Symptoms

Controlling Herxheimer reactions (immunopathology) to maintain tolerable symptoms and acceptable lab work is the best way to ensure that the therapeutic (necessary and unavoidable) inflammation of IT is minimized and organs are protected. Benicar and IT antibiotic doses need to be adjusted up or down (or antibiotic combinations changed) to successfully control Herxheimer reactions and thus, minimize the risk of organ damage. The dogma that mega-dosing of olmesartan is needed for organ protection has not been shown to be the case in a number of patients with kidney problems, many of whom we have seen improve with lower olmesartan dosing. See Benicar Dosing to Prevent Organ Damage During Therapy.
Medical Journal Articles
Angiotensin II Type 2 Receptor Blockade Increases Bone Mass

Previous in vitro studies had indicated that the renin-agiotensin system may be involved in bone cell regulation. This paper reports that treatment with an angiotensin receptor blocker significantly increased bone mass, due to increased osteoblastic activity as well as suppressed osteoclastic action, in an animal model.

Click here or the title aboveto read the complete paper.
About Chronic Illness Recovery

Chronic Illness Recovery (CIR) requires that patients who are enrolled in their counseling program post online about inflammation therapy (i.e., Marshall Protocol) only at the CIR Forum and that they refrain from posting on patient-to-patient message boards that discuss this treatment.

This policy is necessary to maintain safety and health by ensuring that CIR patients:
  • have their medical condition regularly assessed and managed by a professional clinician
  • are professionally advised about the wide range of medical problems that can occur 
  • receive accurate, up-to-date advice about managing inflammation therapy
  • are assured their physician is aware of all advice given regarding management of IT
  • receive advice about adjustments to prescription medications that is tailored to their individual response to treatment and medical concerns
  • are assured the source of advice about managing IT is experienced medical professionals whose credentials are made public.
Website Posting Policy.